Abstract
A patient with hypertrophic cardiomyopathy, syncope, and frequent ventricular tachycardia was monitored during a syncopal episode. An unrecordable blood pressure and the loss of a left ventricular outflow tract murmur without evidence of arrhythmia suggested a primary haemodynamic mechanism such as reduction in left ventricular volume.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Chmielewski C. A., Riley R. S., Mahendran A., Most A. S. Complete heart block as a cause of syncope in asymmetric septal hypertrophy. Am Heart J. 1977 Jan;93(1):91–93. doi: 10.1016/s0002-8703(77)80177-4. [DOI] [PubMed] [Google Scholar]
- Goodwin J. F., Krikler D. M. Arrhythmia as a cause of sudden death in hypertrophic cardiomyopathy. Lancet. 1976 Oct 30;2(7992):937–940. doi: 10.1016/s0140-6736(76)90896-5. [DOI] [PubMed] [Google Scholar]
- Hardarson T., De la Calzada C. S., Curiel R., Goodwin J. F. Prognosis and mortality of hypertrophic obstructive cardiomyopathy. Lancet. 1973 Dec 29;2(7844):1462–1467. doi: 10.1016/s0140-6736(73)92730-x. [DOI] [PubMed] [Google Scholar]
- Joseph S., Balcon R., McDonald L. Syncope in hypertrophic obstructive cardiomyopathy due to asystole. Br Heart J. 1972 Sep;34(9):974–976. doi: 10.1136/hrt.34.9.974. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Krikler D. M., Davies M. J., Rowland E., Goodwin J. F., Evans R. C., Shaw D. B. Sudden death in hypertrophic cardiomyopathy: associated accessory atrioventricular pathways. Br Heart J. 1980 Mar;43(3):245–251. doi: 10.1136/hrt.43.3.245. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Maron B. J., Epstein S. E., Roberts W. C. Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries. Am J Cardiol. 1979 Jun;43(6):1086–1102. doi: 10.1016/0002-9149(79)90139-5. [DOI] [PubMed] [Google Scholar]
- McKenna W. J., Harris L., Perez G., Krikler D. M., Oakley C., Goodwin J. F. Arrhythmia in hypertrophic cardiomyopathy. II: Comparison of amiodarone and verapamil in treatment. Br Heart J. 1981 Aug;46(2):173–178. doi: 10.1136/hrt.46.2.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McKenna W., Deanfield J., Faruqui A., England D., Oakley C., Goodwin J. Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features. Am J Cardiol. 1981 Mar;47(3):532–538. doi: 10.1016/0002-9149(81)90535-x. [DOI] [PubMed] [Google Scholar]
- Rosing D. R., Kent K. M., Maron B. J., Epstein S. E. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status. Circulation. 1979 Dec;60(6):1208–1213. doi: 10.1161/01.cir.60.6.1208. [DOI] [PubMed] [Google Scholar]